03:23 AM EDT, 08/16/2024 (MT Newswires) -- MediWound ( MDWD ) said late Thursday the US Food and Drug Administration has approved NexoBrid for the treatment of pediatric patients with severe thermal burns.
With the approval, the drug is now available for use by all age groups in the US, the company said.
Price: 17.76, Change: -0.41, Percent Change: -2.26